Verastem Inc (NASDAQ: VSTM) open the trading on Thursday, with great promise as it jumped 1.03% to $3.94, before settling in for the price of $3.90 at the close. Taking a more long-term approach, VSTM posted a 52-week range of $2.10-$14.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -45.06% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 24.76%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 24.15%. This publicly-traded company’s shares outstanding now amounts to $40.26 million, simultaneously with a float of $39.64 million. The organization now has a market capitalization sitting at $175.36 million. At the time of writing, stock’s 50-day Moving Average stood at $4.15, while the 200-day Moving Average is $5.35.
Verastem Inc (VSTM) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Verastem Inc’s current insider ownership accounts for 10.94%, in contrast to 49.90% institutional ownership. According to the most recent insider trade that took place on Dec 20 ’24, this organization’s Chief Financial Officer sold 65 shares at the rate of 4.34, making the entire transaction reach 282 in total value, affecting insider ownership by 47,396. Preceding that transaction, on Dec 24 ’24, Company’s Chief Financial Officer sold 28 for 3.91, making the whole transaction’s value amount to 109. This particular insider is now the holder of 47,368 in total.
Verastem Inc (VSTM) Earnings and Revenue Records
Verastem Inc’s EPS increase for this current 12-month fiscal period is 24.15% and is forecasted to reach -2.52 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 1.74% through the next 5 years, which can be compared against the 24.76% growth it accomplished over the previous five years trading on the market.
Verastem Inc (NASDAQ: VSTM) Trading Performance Indicators
Let’s observe the current performance indicators for Verastem Inc (VSTM). It’s Quick Ratio in the last reported quarter now stands at 3.23. The Stock has managed to achieve an average true range (ATR) of 0.40. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 17.54.
In the same vein, VSTM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.19, a figure that is expected to reach -0.81 in the next quarter, and analysts are predicting that it will be -2.52 at the market close of one year from today.
Technical Analysis of Verastem Inc (VSTM)
[Verastem Inc, VSTM] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 7.84% While, its Average True Range was 0.39.
Raw Stochastic average of Verastem Inc (VSTM) in the period of the previous 100 days is set at 45.48%, which indicates a major rise in contrast to 5.38% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 76.82% that was lower than 90.37% volatility it exhibited in the past 100-days period.
